Hemosonics LLC

HemoSonics is a privately held medical device company that specializes in developing innovative in vitro diagnostics to assess and manage hemostasis in acute care settings. Their mission is to provide actionable information for better patient care, particularly in cases involving major bleeding and thrombosis. Product/Service Line Breakdown: Quantra® QPlus® System: A novel point-of-care diagnostic platform designed for managing bleeding by delivering actionable information promptly. In Vitro Diagnostics (IVD): Innovative tools and solutions aimed at characterizing hemostasis to guide management in acute care scenarios. Bleeding Management Technologies: Development of clinical tools and technologies for more effective bleeding management in acute care settings. Acute Care Hemostasis Solutions: Specialized diagnostics tailored for acute care settings to improve patient care and lower overall medical costs. Point-of-Care Bleeding Management: A focus on revolutionizing point-of-care bleeding management with innovative diagnostic solutions.